Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver

Journal of Hepatology

Volumn 65, Issue 4, 2016, Pages 791-797

  Sung, Ki Chul ^a   Ryu, Seungho ^b   Lee, Jong Young ^a   Kim, Jang Young ^c   Wild, Sarah H ^d   Byrne, Christopher D ^e  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Yonsei University Wonju College of Medicine   (South Korea)

^d Centre for Population Health Sciences   (United States)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Exercise; Insulin resistance; Metabolic syndrome; Non alcoholic fatty liver disease; Obesity; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; EXERCISE; EXERCISE INTENSITY; FATTY LIVER; FEMALE; FOLLOW UP; GENERAL HEALTH STATUS ASSESSMENT; HUMAN; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE SHORT FORM; MALE; MASS SCREENING; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

EXERCISE; FATTY LIVER; FEMALE; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84991694211     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.05.026     Document Type: Article

References (28)

1. [1] Byrne, C.D., Targher, G., NAFLD: a multisystem disease. J Hepatol 62 (2015), S47–S64.
2. [2] Armstrong, M.J., Adams, L.A., Canbay, A., Syn, W.K., Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59 (2014), 1174–1197.
3. [3] Tsuneto, A., Hida, A., Sera, N., Imaizumi, M., Ichimaru, S., Nakashima, E., et al. Fatty liver incidence and predictive variables. Hypertens Res 33 (2010), 638–643.
4. [4] Hazlehurst, J.M., Woods, C., Marjot, T., Cobbold, J.F., Tomlinson, J.W., Non-alcoholic fatty liver disease and diabetes. Metabolism 65 (2016), 1096–1108.
5. [5] Sung, K.C., Wild, S.H., Byrne, C.D., Resolution of fatty liver and risk of incident diabetes. J Clin Endocrinol Metab 98 (2013), 3637–3643.
6. [6] Sung, K.C., Wild, S.H., Byrne, C.D., Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. J Hepatol 60 (2014), 1040–1045.
7. [7] Yamazaki, H., Tsuboya, T., Tsuji, K., Dohke, M., Maguchi, H., Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes. Diabetes Care 38 (2015), 1673–1679.
8. [8] Singh, S., Allen, A.M., Wang, Z., Prokop, L.J., Murad, M.H., Loomba, R., Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13 (2015), 643–654 e641–e649; quiz e639–e640.
9. [9] Pais, R., Charlotte, F., Fedchuk, L., Bedossa, P., Lebray, P., Poynard, T., et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 59 (2013), 550–556.
10. [10] Wong, V.W., Wong, G.L., Choi, P.C., Chan, A.W., Li, M.K., Chan, H.Y., et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 59 (2010), 969–974.
11. [11] McPherson, S., Hardy, T., Henderson, E., Burt, A.D., Day, C.P., Anstee, Q.M., Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol 62 (2015), 1148–1155.
12. [12] Byrne, C.D., Targher, G., Time to replace assessment of liver histology with MR-based imaging tests to assess efficacy of interventions for nonalcoholic fatty liver disease. Gastroenterology 150 (2016), 7–10.
13. [13] Mahady, S.E., George, J., Exercise and diet in the management of nonalcoholic fatty liver disease. Metabolism 65 (2016), 1172–1182.
14. [14] Berzigotti, A., Saran, U., Dufour, J.F., Physical activity and liver diseases. Hepatology 63 (2016), 1026–1040.
15. [15] Keating, S.E., Hackett, D.A., George, J., Johnson, N.A., Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 57 (2012), 157–166.
16. [16] Hallsworth, K., Avery, L., Trenell, M.I., Targeting lifestyle behavior change in adults with NAFLD during a 20-min consultation: summary of the dietary and exercise literature. Curr Gastroenterol Rep, 18, 2016, 11.
17. [17] Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142 (2012), 1592–1609.
18. [18] Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., Marchesini, G., A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53 (2010), 372–384.
19. [19] Garber, C.E., Blissmer, B., Deschenes, M.R., Franklin, B.A., Lamonte, M.J., Lee, I.M., et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43 (2011), 1334–1359.
20. [20] Palmentieri, B., de Sio, I., La Mura, V., Masarone, M., Vecchione, R., Bruno, S., et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 38 (2006), 485–489.
21. [21] Saadeh, S., Younossi, Z.M., Remer, E.M., Gramlich, T., Ong, J.P., Hurley, M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002), 745–750.
22. [22] Oh, J., Yang, Y.J., Kim, B., Heon, K.J., Validity and reliability of Korean version of international physical activity questionnaire (IPAQ) short form. Korean J Fam Med 28 (2007), 532–541.
23. [23] Cuthbertson, D.J., Shojaee-Moradie, F., Sprung, V.S., Jones, H., Pugh, C.J., Richardson, P., et al. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 130 (2016), 93–104.
24. [24] Keating, S.E., Hackett, D.A., Parker, H.M., O'Connor, H.T., Gerofi, J.A., Sainsbury, A., et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol 63 (2015), 174–182.
25. [25] Baum, T., Cordes, C., Dieckmeyer, M., Ruschke, S., Franz, D., Hauner, H., et al. MR-based assessment of body fat distribution and characteristics. Eur J Radiol, 2016 Epub ahead of print.
26. [26] Hallsworth, K., Fattakhova, G., Hollingsworth, K.G., Thoma, C., Moore, S., Taylor, R., et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60 (2011), 1278–1283.
27. [27] Rector, R.S., Thyfault, J.P., Morris, R.T., Laye, M.J., Borengasser, S.J., Booth, F.W., et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 294 (2008), G619–G626.
28. [28] Holt, H.B., Wild, S.H., Wood, P.J., Zhang, J., Darekar, A.A., Dewbury, K., et al. Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia 49 (2006), 141–148.